Share of cumulative clinical trials starts by cancer type global 2000-2018

This statistic depicts the percentage of cumulative clinical trials started globally between 2000 and 2018, by cancer type. During these years, lung cancer-related clinical trials made up 3.1 percent of all clinical trials, followed closely by breast cancer with three percent of clinical trials started.

Percentage of cumulative clinical trials started worldwide between 2000 and 2018, by cancer type*

Type of cancer	Percentage of cumulative clinical trials started
Lung	3.1%
Breast	3%
Leukemia	2.9%
Lymphoma	2.8%
Prostate	1.4%
Myeloma	1.3%
Colorectal	1.2%
Brain/Glioma/CNS	1.2%
Renal	1.1%
Head and neck	1.1%
Melanoma	1%
Pancreatic	1%
Ovarian	1%
Stomach	1%
Myelodysplastic syndromes (MDS)	0.8%
Other indications**	9.6%

Loading statistic...

Download

Source

Show detailed source information?

Already a member?

Sources

Use Ask Statista Research Service

Release date

November 2019

More information

Region

Worldwide

Survey time period

2000 to 2018

Supplementary notes

* Trials looking at two or more indications are repeat counted for each indication.
** “Other indications” includes those indications not shown as well as tumor-agnostic trials that do not specify any tumor type; if a trial lists both specified and unspecified tumor types, then it would be counted under each of the specified tumor types.

Citation formats